Up-to-date on mortality in COPD - report from the OLIN COPD study - Wikidata - awgldk - TriplyDB

Up-to-date on mortality in COPD - report from the OLIN COPD study

Up-to-date on mortality in COPD - report from the OLIN COPD study

http://www.wikidata.org/entity/Q34122162

about

Relationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysis A Novel Remote Rehabilitation System with the Fusion of Noninvasive Wearable Device and Motion Sensing for Pulmonary Patients.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation.Comorbidities and burden of COPD: a population based case-control study.Chronic obstructive pulmonary disease (COPD) during the two last years of life--a retrospective study of decedents.Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population--a population based cohort study.Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease--ECG-findings in a population-based cohort study.Risk of Periodontal Diseases in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population-based Cohort Study.Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers.Ischemic ECG abnormalities are associated with an increased risk for death among subjects with COPD, also among those without known heart disease.Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Ob Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.Effect of Liuweibuqi capsules on the balance between MMP-9 and TIMP1 and viability of alveolar macrophages in COPD.Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population.Fatigue Affects Health Status and Predicts Mortality Among Subjects with COPD: Report from the Population-Based OLIN COPD Study.Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD.

P2860

Q28076457-1AAD915D-2F16-4331-AA6F-E0EA314047B8 Q33696483-1E064EBC-5F08-4699-9544-1748C7C8559C Q34065276-F4D4F432-0920-4A87-A82E-FA2CA5849E6E Q34202072-291E07CF-7FE3-4F78-9804-E6053E5B057E Q34730130-55E8E032-9B1E-4C72-9D21-CCC1F2E47D8E Q35075671-99E7F237-41ED-4940-AF05-AF16ECDD544F Q35128794-8C8476A8-74FC-4B95-A423-2A0796EDB78F Q35861330-A3AE69DA-0397-436C-AFB1-803AA6DCCB9B Q36299295-3D1DBBC6-2B10-4005-8D73-683D700E41E9 Q38155607-853D4474-9C39-4CEF-85CC-3118F2C6FF61 Q38598984-BC1AF44A-7A93-4154-8624-5C6142B613C9 Q39497381-44850A3D-1791-4892-B2FD-218B0AEF13C8 Q40854299-4867FCB3-B9E2-4091-8264-122C9E850F94 Q41698292-0A263E36-8A10-4391-B2D0-3F612428C2BD Q47127219-68B28E5F-6D8B-4492-82F5-BE791D5397A4 Q50635241-7F31E76C-DAEC-4480-833B-F49E3108F568 Q55287169-F9AB10C2-1424-45C4-BC29-FB66618C5A0B

P2860

Up-to-date on mortality in COPD - report from the OLIN COPD study

http://www.wikidata.org/entity/Q34122162

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Up-to-date on mortality in COPD - report from the OLIN COPD study

@ast

Up-to-date on mortality in COPD - report from the OLIN COPD study

@en

Up-to-date on mortality in COPD - report from the OLIN COPD study

@nl

type

label

Up-to-date on mortality in COPD - report from the OLIN COPD study

@ast

Up-to-date on mortality in COPD - report from the OLIN COPD study

@en

Up-to-date on mortality in COPD - report from the OLIN COPD study

@nl

prefLabel

Up-to-date on mortality in COPD - report from the OLIN COPD study

@ast

Up-to-date on mortality in COPD - report from the OLIN COPD study

@en

Up-to-date on mortality in COPD - report from the OLIN COPD study

@nl

P1433

Q34122162-6465FDA5-34B4-4229-9486-0F83575DF84A

P1476

Q34122162-064A1345-259E-404C-8D96-F03104ABCA4C

P2093

Q34122162-2F052E6E-A925-431F-9372-49662E22BA2A

Q34122162-4625E49C-9F15-43C9-9D7A-2B5D415B8083

Q34122162-AE5E7EE6-8BB7-40AA-92DF-D0FC248D2777

Q34122162-B752E359-7660-4DE7-8F97-61F75E2EE989

P2860

Q34122162-013330E8-A330-4508-AC2C-268226790C33

Q34122162-027469A7-345E-4E72-A7E9-17F125B0345B

Q34122162-1587E697-1EC9-4E07-92E7-73C9FE0089A4

Q34122162-2604DCF2-B466-46F4-8F50-6FF29F39B8DC

Q34122162-264A1ED7-3FC7-4497-9423-0FE8E2E35E48

Q34122162-3B5E5189-97AA-4768-9E47-589B1A5B4EFE

Q34122162-418A8FB4-139A-4CC9-BB95-E86243227E82

Q34122162-5C9F966C-496A-4894-8B9E-1336BCF99600

Q34122162-60C2A400-1312-4F8B-8240-6067C8C25C6B

Q34122162-6B196A09-DA47-4A0D-A971-4FB9CB86E2C6

P2888

Q34122162-C3D4169D-F631-44CE-BF29-65A9F5FAB837

P304

Q34122162-0F7B482D-43FD-4ABA-A645-AACE13C4C7C5

P31

Q34122162-00AF4CD1-F129-4F77-ACDD-34E10E6B37A3

P356

Q34122162-1E961F9B-7C4D-44EE-963A-FD9ADAD77252

P478

Q34122162-D9349976-776A-4018-90D6-F8836020A717

P50

Q34122162-F69266BB-4E97-4DFC-956A-9E3BDEE7AEDD

P577

Q34122162-5A7908E7-619D-4DC8-B8D5-CA3733A48B5D

P5875

Q34122162-2895A860-449B-4B8D-B935-8AED63B71299

P6179

Q34122162-6C032AB9-1ECE-421D-BA95-8200617C99FA

P698

Q34122162-8AFCE508-A7AB-4D07-AD7C-3C704CC3E37B

P932

Q34122162-DB3CD2E5-DB64-4C09-BAB8-9215399AA29D

P356

P1433

BMC Pulmonary Medicine

P1476

Up-to-date on mortality in COPD - report from the OLIN COPD study

@en

P2093

Bo Lundbäck

http://www.w3.org/2001/XMLSchema#string

Eva Rönmark

http://www.w3.org/2001/XMLSchema#string

Hana Muellerova

http://www.w3.org/2001/XMLSchema#string

Lars-Gunnar Larsson

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis.

Standardization of Spirometry, 1994 Update. American Thoracic Society

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

Does mild COPD affect prognosis in the elderly?

Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age.

Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study.

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.

Decline in lung function and mortality: the Busselton Health Study

The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature.

P2888

P304

1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2466-12-1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221734275

http://www.w3.org/2001/XMLSchema#string

P6179

1007448330

http://www.w3.org/2001/XMLSchema#string

P698

22230685

http://www.w3.org/2001/XMLSchema#string

P932

3276412

http://www.w3.org/2001/XMLSchema#string